BRAF and colorectal carcinoma: We have shown that an mPCR amplicon sequencing assay can classify CRC MSI status and detect BRAF variants with a high level of concordance relative to existing diagnostic methods, and that it can be used to detect MSI in colonoscopic biopsies.